The pharmaceutical water market is predicted to cross a revenue of US$ 71.9 Bn by 2030. This is evident since manufacturers are innovating in pharmaceutical-grade water purification systems. For instance, Puretech designs water purification systems for pharmaceutical, cosmetics, and biopharma industries. Service providers are offering installation, commission, and validation of purification systems to pharmaceutical end users. Innovations in these systems are becoming prominent in European countries where regional manufacturers are strengthening their global distribution chains.
πππ πππ¦π©π₯π πππ©π¨π«π πππ : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79585
Equipment manufacturers are complying with worldwide pharmacopoeia standards. Cutting-edge water purification systems are helping manufacturers in the pharmaceutical water market to gain recognition. Equipment companies are meeting client specifications and requirements to increase the uptake of systems. Pre-treatment activities are fueling the demand for pharmaceutical-grade water purification systems. Region-specific needs are being catered by equipment manufacturers due to different degrees of pre-treatment methods.
- Prominent players operating in the global pharmaceutical water market include
- Merck KGaA,
- Β B. Braun Melsungen AG,
- Baxter International, Inc.,
- Thermo Fisher Scientific, Inc.,
- Cytiva (Danaher),
- Intermountain Life Sciences,
- Standard Reagents, Pvt. Ltd.,
- CovaChem, LLC.,
- FUJIFILM Irvine Scientific,
- Fresenius Kabi AG,
- Pfizer, Inc.